Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Myles Wolf

Showing results (151-160 of 308) with videos related to

Pageof 31
Sort By:
Diabetes Research and Clinical Practice|March 10, 2012
Tubular markers are associated with decline in kidney function in proteinuric type 2 diabetic patientsStine E Nielsen, Henrik Reinhard, Dietmar Zdunek, et al.
Kidney International|May 10, 2013
Plasma FGF23 levels increase rapidly after acute kidney injuryMarta Christov, Sushrut S Waikar, Renata C Pereira, et al.
Journal of Renal Nutrition : the Official Journal of the Council on Renal Nutrition of the National Kidney Foundation|March 10, 2020
Racial Differences in the Associations Between Food Insecurity and Fibroblast Growth Factor 23 in the Coronary Artery Risk Development in Young Adults StudyLindsay R Pool, Kiarri N Kershaw, Penny Gordon-Larsen, et al.
Clinical Journal of the American Society of Nephrology : CJASN|October 26, 2014
Fibroblast growth factor 23 and incident CKD in type 2 diabetesTamara Isakova, Timothy E Craven, Jungwha Lee, et al.
Neurology|April 8, 2014
Plasma FGF23 and the risk of stroke: the Northern Manhattan Study (NOMAS)Clinton B Wright, Chuanhui Dong, Matthew Stark, et al.
Hypertension (Dallas, Tex. : 1979)|March 17, 2004
Insulin resistance and alterations in angiogenesis: additive insults that may lead to preeclampsiaRavi Thadhani, Jeffrey L Ecker, Walter P Mutter, et al.
Kidney International Reports|September 18, 2024
Design and Rationale of the Phase 2 Baricitinib Study in Apolipoprotein L1-Mediated Kidney Disease (JUSTICE)Opeyemi A Olabisi, Nadine J Barrett, Anika Lucas, et al.
Clinical Journal of the American Society of Nephrology : CJASN|March 11, 2026
Effect of Clazakizumab on Neutrophil-Lymphocyte Ratio in Patients Receiving Hemodialysis: Secondary Analysis of the POSIBIL6ESKD Phase 2b TrialBenjamin Catanese, Mark Heise, Anna M Chang, et al.
Transplantation|March 2, 2011
Association of serum phosphorus level with anemia in kidney transplant recipientsCsaba P Kovesdy, Istvan Mucsi, Maria E Czira, et al.
Hypertension (Dallas, Tex. : 1979)|January 11, 2007
Agonistic angiotensin II type 1 receptor autoantibodies in postpartum women with a history of preeclampsiaCarl A Hubel, Gerd Wallukat, Myles Wolf, et al.
Pageof 31

Showing results (151-160 of 308) with videos related to

Sort By:
Pageof 31
Diabetes Research and Clinical Practice|March 10, 2012
Tubular markers are associated with decline in kidney function in proteinuric type 2 diabetic patientsStine E Nielsen, Henrik Reinhard, Dietmar Zdunek, et al.
Kidney International|May 10, 2013
Plasma FGF23 levels increase rapidly after acute kidney injuryMarta Christov, Sushrut S Waikar, Renata C Pereira, et al.
Journal of Renal Nutrition : the Official Journal of the Council on Renal Nutrition of the National Kidney Foundation|March 10, 2020
Racial Differences in the Associations Between Food Insecurity and Fibroblast Growth Factor 23 in the Coronary Artery Risk Development in Young Adults StudyLindsay R Pool, Kiarri N Kershaw, Penny Gordon-Larsen, et al.
Clinical Journal of the American Society of Nephrology : CJASN|October 26, 2014
Fibroblast growth factor 23 and incident CKD in type 2 diabetesTamara Isakova, Timothy E Craven, Jungwha Lee, et al.
Neurology|April 8, 2014
Plasma FGF23 and the risk of stroke: the Northern Manhattan Study (NOMAS)Clinton B Wright, Chuanhui Dong, Matthew Stark, et al.
Hypertension (Dallas, Tex. : 1979)|March 17, 2004
Insulin resistance and alterations in angiogenesis: additive insults that may lead to preeclampsiaRavi Thadhani, Jeffrey L Ecker, Walter P Mutter, et al.
Kidney International Reports|September 18, 2024
Design and Rationale of the Phase 2 Baricitinib Study in Apolipoprotein L1-Mediated Kidney Disease (JUSTICE)Opeyemi A Olabisi, Nadine J Barrett, Anika Lucas, et al.
Clinical Journal of the American Society of Nephrology : CJASN|March 11, 2026
Effect of Clazakizumab on Neutrophil-Lymphocyte Ratio in Patients Receiving Hemodialysis: Secondary Analysis of the POSIBIL6ESKD Phase 2b TrialBenjamin Catanese, Mark Heise, Anna M Chang, et al.
Transplantation|March 2, 2011
Association of serum phosphorus level with anemia in kidney transplant recipientsCsaba P Kovesdy, Istvan Mucsi, Maria E Czira, et al.
Hypertension (Dallas, Tex. : 1979)|January 11, 2007
Agonistic angiotensin II type 1 receptor autoantibodies in postpartum women with a history of preeclampsiaCarl A Hubel, Gerd Wallukat, Myles Wolf, et al.
Pageof 31